| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |